Immunic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.About IMUX
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
CEODaniel Vitt
CEODaniel Vitt
Employees91
Employees91
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2003
Founded2003
Employees91
Employees91
IMUX Key Statistics
Market cap89.25M
Market cap89.25M
Price-Earnings ratio-0.95
Price-Earnings ratio-0.95
Dividend yield—
Dividend yield—
Average volume1.25M
Average volume1.25M
High today$0.9998
High today$0.9998
Low today$0.8901
Low today$0.8901
Open price$0.90
Open price$0.90
Volume669.91K
Volume669.91K
52 Week high$2.11
52 Week high$2.11
52 Week low$0.561
52 Week low$0.561
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own IMUX. This list is generated using Robinhood data, and it’s not a recommendation.